We are live on ! Find out more
SI

Sofinnova Investments Portfolio holdings

AUM $2.63B
1-Year Est. Return 117.41%
This Fund
S&P 500
This Quarter Est. Return
-7.85%
1 Year Est. Return
+117.41%
3 Year Est. Return
+428.82%
5 Year Est. Return
+748.21%
10 Year Est. Return
–
AUM
$1.32B
AUM Growth
-$394M
Cap. Flow
-$88.3M
Cap. Flow %
-6.7%
Top 10 Hldgs %
63.8%
Holding
83
New
13
Increased
13
Reduced
16
Closed
22

Top Buys

Rank Stock Value
1
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$114M
2
AZN icon
AstraZeneca
AZN
+$33.2M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$22.5M
4
ZTS icon
Zoetis
ZTS
+$21.1M
5
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$17.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$42.2M
2
BPMC
Blueprint Medicines
BPMC
+$26.3M
3
ALGN icon
Align Technology
ALGN
+$25.1M
4
HRTX icon
Heron Therapeutics
HRTX
+$21.4M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$20.9M

Sector Composition

Rank Sector Weight
1 Healthcare 89.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
76
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
– –
-100,000
Closed -$47.5M
VIR icon
77
PUT
Vir Biotechnology
VIR
$1.49B
– –
-200,000
Closed -$8.37M
ZYME icon
78
Zymeworks
ZYME
$1.66B
– –
-392,712
Closed -$6.44M
ITCI
79
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-56,915
Closed -$2.98M
MRNS
80
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-171,338
Closed -$2.04M
CYT
81
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
– –
-179,450
Closed -$2.04M
1 2 3
4

Similar funds

WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
WCA
Waratah Capital Advisors Toronto, Ontario, Canada $2.63B AUM 76.33% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
NIG
NFJ Investment Group Dallas, Texas $2.64B AUM 23.86% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Sofinnova Investments's Q1 2022 Portfolio in Review

As of Q1 2022, Sofinnova Investments held 83 positions worth $1.32B, down 23% from $1.71B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Sofinnova Investments withdrew a net $88.3M in Q1 2022, closing 22 positions and reducing 16 holdings. Its most notable exit was AbbVie, an estimated $42.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 85% a quarter earlier.

Against the trend, Sofinnova Investments opened a new position in CinCor Pharma, Inc. Common Stock worth $97.8M.

  • Sofinnova Investments's largest Q1 2022 buy was CinCor Pharma, Inc. Common Stock: 5,573,949 shares worth $97.8M.
  • Sofinnova Investments added most to United Therapeutics in Q1 2022, an estimated $13.2M increase.
  • Sofinnova Investments's biggest Q1 2022 reduction was Heron Therapeutics, cutting an estimated $21.4M.
  • Sofinnova Investments fully exited AbbVie in Q1 2022, selling an estimated $42.2M.
  • Sofinnova Investments's ten largest holdings make up 64% of its $1.32B portfolio in Q1 2022.
  • Sofinnova Investments opened 13 new positions and closed 22 in Q1 2022.
  • Sofinnova Investments's portfolio value fell 23% quarter-over-quarter to $1.32B.

Based on Sofinnova Investments's 13F filing for Q1 2022, filed 16 May 2022.